Cargando…
胸膜间皮瘤免疫治疗研究进展
Patients with malignant pleural mesothelioma (MPM) usually present with poor prognosis and short survival period, and there has been a lack of effective treatment options for a long time. Chemotherapy has limited improvement in the clinical outcome of advanced patients (the median survival is less t...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051308/ https://www.ncbi.nlm.nih.gov/pubmed/35477190 http://dx.doi.org/10.3779/j.issn.1009-3419.2022.101.17 |